Chakma Justin's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Dec 13, 2024
- Accession no.
- 0001415889-24-029377
- Filed
- Dec 13, 2024
- Trade date
- Dec 12-13, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.77M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chakma JustinCIK 0001951238 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | Common Stock | MOption exerciseAcquired | +117,333 | $0.84 | +$98,559.72 | 253,713 | Direct | |
| Dec 12, 2024 | Common Stock | SSaleDisposed | −117,333 | $12.27 | −$1,439,675.91 | 136,380 | Direct | |
| Dec 13, 2024 | Common Stock | MOption exerciseAcquired | +27,272 | $1.44 | +$39,271.68 | 163,652 | Direct | |
| Dec 13, 2024 | Common Stock | SSaleDisposed | −27,272 | $12.06 | −$328,900.32 | 136,380 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | Common Stock | MOption exerciseDisposed | −117,333 | $0.00 | $0 | 119,047 | Direct | |
| Dec 13, 2024 | Common Stock | MOption exerciseDisposed | −27,272 | $0.00 | $0 | 55,461 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.